Revolution Medicines, Inc. (RVMD)

Revolution Medicines, Inc. records an AlphaScore of 65/100 in the healthcare sector, receiving a watch signal. Key quantitative measures display a debt-to-equity ratio of 0.46 and a forward P/E of -32.55. A notable strength is its high quality sub-score of 85, while a major risk is highlighted by its deeply negative return on equity of -69.35% as of October 11, 2026.

Written 11/10/2026, 00:33:54 UTC · Snapshot 11/10/2026